Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting No phase listed Observational

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

ClinicalTrials.gov ID: NCT01915511

Public ClinicalTrials.gov record NCT01915511. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Sep 5, 2026, 4:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) and Interstitial Lung Disease Prospective Outcomes (IPF-PRO/ILD-PRO) Registry

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry started recruiting in 2014 with the objective of studying Idiopathic Pulmonary Fibrosis. In 2018, the registry expanded to include recruitment of participants with other chronic fibrosing interstitial lung diseases (ILDs) with progressive phenotype also referred to as progressive fibrosing interstitial lung diseases in the Chronic Fibrosis Interstitial Lung Disease with Progressive Phenotype (ILD-PRO) Registry. When the third phase of the registry begins, the IPF-PRO registry will enroll additional patients with idiopathic pulmonary fibrosis. This IPF-PRO registry is a prospective registry that will collect information regarding the natural history, health care interactions, participant reported questionnaire data to assess quality of life, and the methods of treatment of participants with a diagnosis of idiopathic pulmonary fibrosis (IPF) or of another chronic fibrosing interstitial lung disease (ILD) with progressive phenotype established at the enrolling centers. In addition, blood samples and chest image studies will be collected and banked for future research projects.

Study identification

NCT ID
NCT01915511
Recruitment status
Recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Duke University
Other
Enrollment
3,000 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
21 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2014
Primary completion
Dec 31, 2027
Completion
Dec 31, 2030
Last update posted
Aug 11, 2026

2014 – 2031

United States locations

U.S. sites
47
U.S. states
27
U.S. cities
41
Facility City State ZIP Site status
University of Alabama - Birmingham Birmingham Alabama 35294 Recruiting
University of Arizona Tucson Arizona 85721 Recruiting
University of California - Los Angeles Los Angeles California 90024 Recruiting
University of Southern California Los Angeles California 90033 Recruiting
Stanford University Stanford California 94305 Recruiting
University of Colorado Aurora Colorado 80045 Recruiting
Yale University New Haven Connecticut 06520 Recruiting
University of Florida Gainesville Florida 32610-3175 Recruiting
University of South Florida Tampa Florida 33606 Recruiting
Emory University Atlanta Georgia 30322 Recruiting
Piedmont Healthcare Austell Georgia 30106 Recruiting
University of Chicago Chicago Illinois 60637 Recruiting
Northwestern University Evanston Illinois 60611 Recruiting
Loyola University Health System Maywood Illinois 60153 Recruiting
University of Kansas Kansas City Kansas 66160 Terminated
Tulane University New Orleans Louisiana 70112 Recruiting
University of Michigan Ann Arbor Michigan 48109 Active, not recruiting
Henry Ford Health Detroit Michigan 48202 Recruiting
University of Minnesota Minneapolis Minnesota 55455 Recruiting
University of Mississippi Medical Center Jackson Mississippi 39216 Recruiting
Washington University St Louis Missouri 63110 Recruiting
NYU Medical Center New York New York 10016 Active, not recruiting
Weill Medical College of Cornell University New York New York 10065 Recruiting
UNC Chapel Hill Chapel Hill North Carolina 27514 Recruiting
Duke University Durham North Carolina 27705 Recruiting
Pulmonix LLC Greensboro North Carolina 27403 Recruiting
PMG Research Wilmington North Carolina 28401 Active, not recruiting
Wake Forest Baptist Health Winston-Salem North Carolina 27157 Recruiting
University of Cincinnati Medical Center Cincinnati Ohio 45267 Active, not recruiting
Cleveland Clinic Cleveland Ohio 44195 Recruiting
The Ohio State University Columbus Ohio 43210 Recruiting
University of Oklahoma Oklahoma City Oklahoma 73104 Recruiting
Oregon Clinic Portland Oregon 97220 Recruiting
Temple University Philadelphia Pennsylvania 19140 Recruiting
Thomas Jefferson University Philadelphia Pennsylvania 19144 Recruiting
Medical University of South Carolina Charleston South Carolina 29425 Recruiting
Vanderbilt University Nashville Tennessee 37232 Recruiting
University of Texas Southwestern Dallas Texas 75235 Recruiting
Baylor University Medical Center at Dallas Dallas Texas 75246 Recruiting
Baylor College of Medicine Houston Texas 77030 Recruiting
Houston Methodist Lung Center Houston Texas 77030 Recruiting
The University of Texas Health Science Center At Houston Houston Texas 77030 Recruiting
University of Utah Salt Lake City Utah 84108 Recruiting
University of Vermont Lung Center Colchester Vermont 05446 Active, not recruiting
University from Virginia Charlottesville Virginia 22908 Active, not recruiting
Inova Falls Church Virginia 22042-3307 Recruiting
The Medical College of Wisconsin Milwaukee Wisconsin 53226 Active, not recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01915511, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 11, 2026 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01915511 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →